Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 713 results found. Search for [ Indian pharmaceutical market ]

Results 1 to 21 of 713
BusinessToday.In
January 17, 2020
Share Market Update: Shares of Reliance Industries (RIL), TCS and HCL Tech were trading higher ahead of their quarterly earnings, scheduled for release later in the day.


Niti Kiran
January 16, 2020
For the month of December, the Indian pharmaceutical market growth stood at 8.8 per cent y-o-y compared to 9.3 per cent in December 2018


PB Jayakumar
January 16, 2020
Wockhardt latest medicines: Wockhardt announces two new drugs for skin infections, its shares rise by 14 per cent intraday. Here's what this means


BusinessToday.In
January 16, 2020
Wockhardt said the two approved new antibiotics, Emrok(IV) & Emrok O are used for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia.


BusinessToday.In
January 16, 2020
Share Market Update: During Thursday's trade, Sensex climbed to a fresh all-time high of 42,059 and Nifty too has hit a new lifetime high of 12,389 from 12,374.25 earlier.


BusinessToday.In
January 10, 2020
Share Market Update: In terms of sector, except private banking, all the other indices traded higher today, with metal and realty indices gaining 1% each.


BusinessToday.In
January 9, 2020
Share Market Update : Domestic indices gained on Thursday on back of bullish global equities after remarks by US President suggested that US and Iran were refraining from further military action.


PB Jayakumar
New Delhi, January 7, 2020
How the merger of MNC giants Bayer and Monsanto is likely to pan out in India


BusinessToday.In
January 3, 2020
Share Market Update: Domestic indices followed global markets that erased early gains on Friday in wake of sharp spike in crude prices after a US strike eliminated a top Iranian commander.


E Kumar Sharma
New Delhi, December 31, 2019
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive


PB Jayakumar
December 28, 2019
Nutraceuticals, which consist of vitamins and minerals, protein supplements, energy drinks and growth supplements, have clocked higher growth than prescription drugs


Rajeev Dubey
New Delhi, December 24, 2019
In an interview with Business Today's Rajeev Dubey, AstraZeneca's Non-executive Chairman, Leif Johansson talks about how the world's 14th largest pharma company is facing multiple challenges, two of which are Brexit and the US-China trade war


E Kumar Sharma
December 18, 2019
Industry watchers, however, say that it may lead to some pharma players opting more for medicines not falling under the drug price control regime


PB Jayakumar
December 17, 2019
According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline


E Kumar Sharma
New Delhi, December 11, 2019
At a time when most pharma companies are cash-strapped, Divis has undertaken big capex with its cash surplus


E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play


BusinessToday.In
November 21, 2019
Ministry of Commerce (MOFCOM), People's Republic of China announced that starting Thursday, the anti-dumping duties on pyridine imports from  India and Japan will be withdrawn


PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PAGES 1 OF 36  12345